154 Data-Informed Evolution of a Medication-Assisted Treatment Program in a County Correctional Facility
In response to the opioid crisis, Montgomery County Correctional Facility was awarded a grant by the state of Pennsylvania to spearhead a MAT program for inmates with opioid use disorder. The program uses common MAT modalities such as buprenorphine, methadone, and injectable naltrexone. To maximize the program’s efficacy and meet the ongoing needs of participants, […]
146 Fighting Opioid Use Disorder From Overdose to Reentry: How Public Health Practices Can Inform Public Safety
A collaborative effort among the Middlesex Sheriff?s Office, service providers, and community health agencies led to the Medication Assisted Treatment and Directed Opioid Recovery program, a nationally recognized model for treating opioid use disorder. This presentation will discuss the development of MATADOR from a single MAT program to a full treatment model and national best […]
142 The Use of Dialectical Behavior Therapy to Reduce Recidivism Rates
Recent research finds that traditional cognitive behavioral therapy approaches do not affect recidivism or release rates. A more specific approach to CBT, dialectical behavior therapy, has much more promising results within the specialized population of the incarcerated. This talk will teach DBT skills and methods in detail for immediate use. It also will cover the […]
135 Reaching Youth Through Adult Role Models by Providing Education on Electronic Cigarettes and Vaping
Electronic cigarettes are the most used tobacco product among youth, and popularity has been growing at an alarming rate. The CDC reports that e-cigarette use among middle and high school students increased by over 900% in 2015. This presentation will share information on common devices used for vaping, substances found in e-cigarettes, health effects of […]
129 Measuring Success in an Addiction Medicine Program at the Cuyahoga County Correction Center
This program grew from the initial goal to provide buprenorphine for pregnant females with opiate use disorder. What followed was the creation of a broader program to provide medication-assisted treatment for the general population. The drug courts identified potential candidates who were screened for the naltrexone program, and now offers buprenorphine options. The goal is […]
120 Synthetic Cannabinoids Behind the Walls
Synthetic cannabinoids, also called K2 or Spice, have become the most prevalent drug inside jails and prisons. This presentation will provide an overview of this drug crisis from a patient care perspective and discuss the multitude of concerns it presents for staff members who are exposed unwillingly on a regular basis. Learning Objectives: Differentiate between […]
